[DPHARMA] QoQ Annualized Quarter Result on 30-Jun-2017 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 11.49%
YoY- 55.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 533,036 467,987 474,312 480,710 483,976 312,940 318,542 40.99%
PBT 53,020 51,796 51,961 49,528 44,704 31,479 33,573 35.65%
Tax -10,432 -9,696 -11,518 -11,118 -10,232 -4,653 -9,580 5.84%
NP 42,588 42,100 40,442 38,410 34,472 26,826 23,993 46.65%
-
NP to SH 43,128 42,492 40,829 38,434 34,472 27,115 25,156 43.29%
-
Tax Rate 19.68% 18.72% 22.17% 22.45% 22.89% 14.78% 28.53% -
Total Cost 490,448 425,887 433,869 442,300 449,504 286,114 294,549 40.52%
-
Net Worth 206,429 479,809 474,230 463,071 463,071 454,703 451,913 -40.71%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div - 23,711 - 13,947 - 18,132 - -
Div Payout % - 55.80% - 36.29% - 66.87% - -
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 206,429 479,809 474,230 463,071 463,071 454,703 451,913 -40.71%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 7.99% 9.00% 8.53% 7.99% 7.12% 8.57% 7.53% -
ROE 20.89% 8.86% 8.61% 8.30% 7.44% 5.96% 5.57% -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 191.08 167.76 170.03 172.32 173.49 112.18 114.19 40.99%
EPS 15.28 15.09 14.49 13.76 13.72 9.62 8.60 46.74%
DPS 0.00 8.50 0.00 5.00 0.00 6.50 0.00 -
NAPS 0.74 1.72 1.70 1.66 1.66 1.63 1.62 -40.71%
Adjusted Per Share Value based on latest NOSH - 278,959
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 55.37 48.61 49.27 49.94 50.28 32.51 33.09 40.98%
EPS 4.48 4.41 4.24 3.99 3.58 2.82 2.61 43.40%
DPS 0.00 2.46 0.00 1.45 0.00 1.88 0.00 -
NAPS 0.2144 0.4984 0.4926 0.481 0.481 0.4723 0.4694 -40.71%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 2.80 2.53 2.20 2.25 2.31 1.98 2.06 -
P/RPS 1.47 1.51 1.29 1.31 1.33 1.76 1.80 -12.64%
P/EPS 18.11 16.61 15.03 16.33 18.69 20.37 22.84 -14.34%
EY 5.52 6.02 6.65 6.12 5.35 4.91 4.38 16.69%
DY 0.00 3.36 0.00 2.22 0.00 3.28 0.00 -
P/NAPS 3.78 1.47 1.29 1.36 1.39 1.21 1.27 107.05%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 21/11/16 -
Price 3.35 2.97 2.20 2.03 2.32 2.23 2.10 -
P/RPS 1.75 1.77 1.29 1.18 1.34 1.99 1.84 -3.29%
P/EPS 21.67 19.50 15.03 14.73 18.77 22.94 23.29 -4.69%
EY 4.62 5.13 6.65 6.79 5.33 4.36 4.29 5.06%
DY 0.00 2.86 0.00 2.46 0.00 2.91 0.00 -
P/NAPS 4.53 1.73 1.29 1.22 1.40 1.37 1.30 130.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment